Biodexa Pharmaceuticals (BDRX) Goodwill & Intangibles (2013 - 2025)

Biodexa Pharmaceuticals (BDRX) has 13 years of Goodwill & Intangibles data on file, last reported at $7.5 million in Q4 2025.

• For the quarter ending Q4 2025, Goodwill & Intangibles rose 3.62% year-over-year to $7.5 million; the trailing twelve-month figure through Dec 2025 stood at $7.5 million (up 3.62% YoY), and the FY2025 full-year result was $7.4 million, up 2.71% from the prior year.
• Goodwill & Intangibles was little changed at $7.5 million in Q4 2025, from $7.5 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $18.0 million in Q4 2021 to a low of $6256.8 in Q2 2023.
• A 5-year average of $6.2 million and a median of $7.2 million in 2024 frame the typical range for Goodwill & Intangibles.
• Across the five-year window, Goodwill & Intangibles tumbled 99.5% in 2023 and soared 121102.58% in 2024, its largest moves.
• Tracing BDRX's Goodwill & Intangibles over 5 years: stood at $18.0 million in 2021, then slumped by 85.1% to $2.7 million in 2022, then jumped by 35.84% to $3.7 million in 2023, then soared by 98.53% to $7.2 million in 2024, then grew by 3.62% to $7.5 million in 2025.
• Business Quant data shows BDRX's Goodwill & Intangibles at $7.5 million in Q4 2025, $7.5 million in Q2 2025, and $7.2 million in Q4 2024.